严重喘中的单克隆抗体:实际数据的结果
Silvia Del-Barrio-Buesa1,2, Álvaro Narrillos-Moraza1,2, Julia García-de-Pedro2,3,4
1Department of Pharmacy, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Frontiers in medicine
|August 28, 2025
概括
在实践中使用四种单克隆抗体,在12个月内改善了严重喘和肺功能. 这些生物药物表现出高度的坚持性和持续性,支持它们在治疗严重喘方面的有效性.
科学领域:
- 肺病学
- 免疫学
- 药理学
背景情况:
- 严重的喘带来了重大的临床和经济挑战,特别是对于伴随性疾病或对标准治疗反应不佳的患者.
- 针对2型 (T2) 炎症的单克隆抗体对于治疗严重喘至关重要,但它们的实际有效性需要进一步研究.
研究的目的:
- 评估本拉利祖马布,梅波利祖马布,奥马利祖马布和复利祖马布在12个月内的非控制性严重喘患者中的实际有效性,坚持性和持续性.
主要方法:
- 一项回顾性观察研究分析了从2015年至2022年接受本拉利祖马布,梅波利祖马布,奥马利祖马布或复利祖马布治疗的154名严重喘患者的数据.
- 结果包括在基线和12个月评估的乙氨基酸计数,FEV1,FeNO,ACT分数,恶化,医疗保健利用率,坚持和持续性.
主要成果:
- 所有单克隆抗体在12个月内显著改善了喘控制 (ACT得分+6) 和肺功能 (FEV1+7%).
- 血中乙酸细胞的数量显著下降,本拉利祖马布和复利祖马布的数量几乎完全减少.
- 治疗的坚持率很高 (95%),持续时间中位数为2. 0年,但42%的患者因缺乏反应或供应问题而停止治疗.
结论:
- 贝纳利祖马布,梅波利祖马布,奥马利祖马布和复利祖马布有效改善严重的喘控制,肺功能,并减少现实环境中的恶化.
- 生物药物之间的可比有效性表明个性化,以表型驱动的选择是关键.
- 支持这些生物制剂的可行性,强调需要长期监测.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
451
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
451
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:19Antiasthma Drugs: Leukotriene Modifiers
461
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
461
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
377
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
377
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:20Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576